{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:49:18Z","timestamp":1778291358107,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10067-019-04520-6","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T06:02:55Z","timestamp":1553925775000},"page":"1385-1391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and\/or high serum uric acid levels: a prospective cohort study"],"prefix":"10.1007","volume":"38","author":[{"given":"Iris J. M.","family":"Disveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahel","family":"Zoakman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim L. Th. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard A.","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura B. E.","family":"Kienhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein J. E. M.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-7837","authenticated-orcid":false,"given":"Matthijs","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"issue":"10100","key":"4520_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"GBD 2016 Causes of Death Collaborators","year":"2017","unstructured":"GBD 2016 Causes of Death Collaborators (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet 390(10100):1151\u20131210","journal-title":"Lancet"},{"key":"4520_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/rheumatology\/kep364","volume":"49","author":"CF Kuo","year":"2010","unstructured":"Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS et al (2010) Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) 49:141\u2013146","journal-title":"Rheumatology (Oxford)"},{"key":"4520_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jbspin.2011.01.007","volume":"78","author":"CF Kuo","year":"2011","unstructured":"Kuo CF, Yu KH, See LC, Chou IJ, Tseng WY, Chang HC, Shen YM, Luo SF (2011) Elevated risk of mortality among gout patients: a comparison with the national population in Taiwan. Joint Bone Spine 78:577\u2013580","journal-title":"Joint Bone Spine"},{"issue":"10","key":"4520_CR4","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archinte.168.10.1104","volume":"168","author":"E Krishnan","year":"2008","unstructured":"Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH, MRFIT Research Group (2008) Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 168(10):1104\u20131110","journal-title":"Arch Intern Med"},{"issue":"1","key":"4520_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","volume":"73","author":"F Perez-Ruiz","year":"2014","unstructured":"Perez-Ruiz F, Martinez-Indart L, Carmona L, Herrero-Beites AM, Pijoan IJ, Krihnan E (2014) Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 73(1):177\u2013182","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4520_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jbspin.2011.09.011","volume":"79","author":"CF Kuo","year":"2012","unstructured":"Kuo CF, Luo SF, See LC, Chou IJ, Fang YF, Yu KH (2012) Increased risk of cancer among gout patients: a nationwide population study. Joint Bone Spine 79(4):375\u2013378","journal-title":"Joint Bone Spine"},{"key":"4520_CR7","unstructured":"Knoema (2015) World and Regional Statistics. Netherlands\u2014mortality\u2014crude death rate. https:\/\/knoema.com"},{"key":"4520_CR8","unstructured":"Eurostat (2015) Major causes of death for persons aged 65 and over (standardized date rates per 100.000 inhabitants). https:\/\/ec.europa.eu"},{"key":"4520_CR9","doi-asserted-by":"crossref","unstructured":"Disveld IJM, Fransen J, Rongen GA, Kienhorst LBE, Zoakman S, Janssens HJEM et al Crystal-proven gout and characteristic gout severity factors are associated with cardiovascular disease. J Rheumatol 45(6):858\u2013863","DOI":"10.3899\/jrheum.170555"},{"key":"4520_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/fampra\/cmg413","volume":"20","author":"HJ Janssens","year":"2003","unstructured":"Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M (2003) Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract 20:413\u2013416","journal-title":"Fam Pract"},{"issue":"1368","key":"4520_CR11","first-page":"53","volume":"126","author":"D Winnard","year":"2012","unstructured":"Winnard D, Wright C, Jackson G, Gow P, Kerr A, McLachlan A, Orr-Walker B, Dalbeth N (2012) Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J 126(1368):53\u201364","journal-title":"N Z Med J"},{"key":"4520_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med 125:679\u201387.e1","journal-title":"Am J Med"},{"issue":"4","key":"4520_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ndt\/gfu352","volume":"30","author":"J Jing","year":"2015","unstructured":"Jing J, Kielstein JT, Schultheiss UT, Sitter T, Titze SI, Schaeffner ES, McAdams-DeMarco M, Kronenberg F, Eckardt KU, Kottgen A, for the GCKD Study Investigators, GCKD Study Investigators, Eckardt KU, Titze S, Prokosch HU, Barthlein B, Reis A, Ekici AB, Gefeller O, Hilgers KF, Hubner S, Avendano S, Becker-Grosspitsch D, Hauck N, Seuchter SA, Hausknecht B, Rittmeier M, Weigel A, Beck A, Ganslandt T, Knispel S, Dressel T, Malzer M, Floege J, Eitner F, Schlieper G, Findeisen K, Arweiler E, Ernst S, Unger M, Lipski S, Schaeffner E, Baid-Agrawal S, Petzold K, Schindler R, Kottgen A, Schultheiss U, Meder S, Mitsch E, Reinhard U, Walz G, Haller H, Lorenzen J, Kielstein JT, Otto P, Sommerer C, Follinger C, Zeier M, Wolf G, Busch M, Paul K, Dittrich L, Sitter T, Hilge R, Blank C, Wanner C, Krane V, Schmiedeke D, Toncar S, Cavitt D, Schonowsky K, Borner-Klein A, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schonherr S, Weissensteiner H, Oefner P, Gronwald W, Zacharias H, Schmid M (2015) Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German chronic kidney disease (GCKD) study. Nephrol Dial Transplant 30(4):613\u2013621","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4520_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the third National Health and nutrition examination survey. Arthritis Rheum 57(1):109\u2013115","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4520_CR15","doi-asserted-by":"publisher","first-page":"e000282","DOI":"10.1136\/bmjopen-2011-000282","volume":"2","author":"E Krishnan","year":"2012","unstructured":"Krishnan E (2012) Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open 2(1):e000282","journal-title":"BMJ Open"},{"issue":"8","key":"4520_CR16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/eurjhf\/hfs086","volume":"14","author":"BA Hueskes","year":"2012","unstructured":"Hueskes BA, Willems FF, Leen AC, Ninaber PA, Westra R, Mantel-Teeuwisse AK et al (2012) A case-control study of determinants for the occurrence of gouty arthritis in heart failure patients. Eur J Heart Fail 14(8):916\u2013921","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"4520_CR17","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.24612","volume":"61","author":"SY Kim","year":"2009","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2009) Hyperuricaemia and risk of stroke: a systemic review and meta-analysis. Arthritis Rheum 61(7):885\u2013892","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4520_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","volume":"62","author":"SY Kim","year":"2010","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2010) Hyperuricemia and coronary heart disease: a systemic review and meta-analysis. Arthritis Care Res 62(2):170\u2013180","journal-title":"Arthritis Care Res"},{"issue":"12","key":"4520_CR19","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/art.39330","volume":"67","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Peloquin CE, Dubreuil M, Roddy E, Lu N, Neogi T, Choi HK (2015) Sleep apnea and the risk of incident gout: a population-based, body index-matched cohort study. Arthritis Rheum 67(12):3298\u20133302","journal-title":"Arthritis Rheum"},{"issue":"12","key":"4520_CR20","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1002\/art.39318","volume":"67","author":"LBE Kienhorst","year":"2015","unstructured":"Kienhorst LBE, van Lochem E, Kievit W, Dalbeth M, Merriman ME, Phipps-Green A et al (2015) Gout is a chronic inflammatory disease in which high levels of interleukin 8 (CXCL8) , myeloid-related protein 8\/myoloid related protein 14 complex, and an altered proteome associated with diabetes mellitus and cardiovascular disease. Arthritis Rheum 67(12):3303\u20133313","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4520_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/BOR.0000000000000366","volume":"29","author":"MC Cleophas","year":"2017","unstructured":"Cleophas MC, Crisan TO, Joosten LAB (2017) Factors modulating the inflammatory response in acute gouty arthritis. Curr Opin Rheumatol 29(2):163\u2013170","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"4520_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jbspin.2016.10.013","volume":"84","author":"LBE Kienhorst","year":"2017","unstructured":"Kienhorst LBE, Janssens H, Radstake T, van Riel P, Jacobs J, van Koolwijk E, van Lochem E, Janssen M (2017) A pilot study of CXCL8 levels in crystal proven gout patients during allopurinol treatment and their association with cardiovascular disease. Joint Bone Spine 84(6):709\u2013713","journal-title":"Joint Bone Spine"},{"key":"4520_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2001-1326-1-16","volume":"1","author":"MA Fini","year":"2012","unstructured":"Fini MA, Elias A, Johnson RJ, Wright RM (2012) Contributions of uric acid to cancer risk, recurrence and mortality. Clin Transl Med 1:16","journal-title":"Clin Transl Med"},{"issue":"7","key":"4520_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/annrheumdis-2016-210538","volume":"76","author":"N Vazirpanah","year":"2017","unstructured":"Vazirpanah N, Kienhorst LBE, Van Lochem E, Wichers C, Rossato M, Shiels PG et al (2017) Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout. Ann Rheum Dis 76(7):1313\u20131319","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"4520_CR25","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s10067-017-3840-1","volume":"36","author":"TL Jansen","year":"2017","unstructured":"Jansen TL, Janssen M (2017) The American College of Physicians and the 2017 guideline for the management of acute and recurrent gout: treat to avoiding symptoms versus treat to target. Clin Rheumatol 36(11):2399\u20132402","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4520_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M16-0570","volume":"166","author":"A Quaseem","year":"2017","unstructured":"Quaseem A, Harris RP, Forciea MA (2017) Clinical Guidelines Committee of the American College of physicians. Management of acute and recurrent gout: a clinical practice guideline from the American college of physicians. Ann Intern Med 166(1):58\u201368","journal-title":"Ann Intern Med"},{"issue":"1","key":"4520_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barkova V, Becce F, Casta\u00f1eda-Sanabria J et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04520-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:23:26Z","timestamp":1721129006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04520-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4520"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04520-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}